Meehan Steven 4
4 · Kadmon Holdings, Inc. · Filed Nov 9, 2021
Insider Transaction Report
Form 4
Meehan Steven
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2021-11-09$5.38/sh−25,000$134,500→ 0 totalExercise: $4.12Exp: 2027-06-29→ Common Stock, par value $0.001 (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2021-11-09$5.16/sh−500,000$2,580,000→ 0 totalExercise: $4.34Exp: 2030-01-27→ Common Stock, par value $0.001 (500,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2021-11-09$5.54/sh−1,020,000$5,650,800→ 0 totalExercise: $3.96Exp: 2031-01-08→ Common Stock, par value $0.001 (1,020,000 underlying) - Disposition to Issuer
Common Stock
2021-11-09$9.50/sh−24,909$236,636→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2021-11-09$6.15/sh−25,000$153,750→ 0 totalExercise: $3.35Exp: 2028-07-27→ Common Stock, par value $0.001 (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2021-11-09$7.33/sh−400,000$2,932,000→ 0 totalExercise: $2.17Exp: 2029-02-08→ Common Stock, par value $0.001 (400,000 underlying)
Footnotes (3)
- [F1]Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").
- [F2]In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option
- [F3]Represents the payment per share of Common Stock received in exchange for the cancellation of each Option.